ACAD vs JNPR · P/E 15, rev $576.0M vs P/E 38, $13.36B cap
ACADIA Pharmaceuticals Inc (ACAD) versus Juniper Networks Inc (JNPR) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Juniper Networks Inc (JNPR) is a communication equipment company listed on US.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
JNPR does not have a complete income-statement cache yet.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. JNPR currently screens at market cap $13.36B and trailing P/E 38.0.
Not investment advice. Open the ACAD and JNPR stock pages for the full models.
Not investment advice.